HER2 Support Group Forums - View Single Post - KIYATEC enrolls first patients with solid tumors in clinical study of its EV3D drug r

News · 06-20-2018, 07:32 AM

KIYATEC, Inc. today announced the enrollment of the first patients in a U.S. clinical study of its Ex Vivo 3D drug response assay across several difficult-to-treat solid tumors.

More...

06-20-2018, 07:32 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,951	KIYATEC enrolls first patients with solid tumors in clinical study of its EV3D drug r KIYATEC, Inc. today announced the enrollment of the first patients in a U.S. clinical study of its Ex Vivo 3D drug response assay across several difficult-to-treat solid tumors. More...